Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes

Kidney International

Volumn 69, Issue 11, 2006, Pages 2049-2056

  Lin, J L ^a,b   Lin Tan, D T ^a   Yu, C C ^a   Li, Y J ^a   Huang, Y Y ^a   Li, K L ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Blood lead levels; Body lead burden; Diabetic nephropathy; Environmental lead exposure; Lead chelation therapy

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CHELATING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETATE CALCIUM DISODIUM; LEAD; PLACEBO; STATINE DERIVATIVE;

ADULT; AGED; ARTICLE; CHELATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 33745229969     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001505     Document Type: Article

References (33)

1. Wedeen RP, Maesaka JK, Weiner B et al. Occupational lead nephropathy. Am J Med 1975; 59: 630-641.
2. Wedeen RP, Mallick DK, Batuman V. Detection and treatment of occupational lead nephropathy. Arch Intern Med 1979; 139: 53-57.
3. Nuyts GD, Daelemans RA, Jorens PG et al. Does lead play a role in the development of chronic renal disease? Nephrol Dial Transplant 1991; 6: 307-315.
4. Staessen JA, Lauwerys RR, Buchet J-P et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 1992; 327: 151-156.
5. Kim R, Rotnitsky A, Sparrow D et al. A longitudinal study of lowlevel lead exposure and impairment of renal function: the Normative Aging Study. JAMA 1996; 275: 1177-1181.
6. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-659.
7. Obrador GT, Arora P, Kausz AT, Pereira BJ. Pre-end-stage renal disease care in the United States: a state of disrepair. J Am Soc Nephrol 1998; 9(Suppl): S44-S54.
8. Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908-1919.
9. Pollock CA, Ibels LS. Lead nephropathy - a preventable cause of renal failure. Int J Artif Organs 1988; 11: 75-78.
10. Lin JL, Yeh KH, Tseng HC et al. Urinary N-acetyl-glucosaminidase excretion and environmental lead exposure. Am J Nephrol 1993; 13: 442-447.
11. Lin JL, Ho HH, Yu CC. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency: a randomized, controlled trial. Ann Intern Med 1999; 130: 7-13.
12. Lin JL, Tan DT, Hsu KH, Yu CC. Environmental lead exposure and progressive renal insufficiency. Arch Intern Med 2001; 161: 264-271.
13. Yu CC, Lin JL, Lin-Tan DT. Evironmental exposure to lead and progression of chronic renal disease: a four-year prospective longitudinal study. J Am Soc Nephrol 2004; 15: 1016-1022.
14. Lin JL, Tan DT, Ho HH, Yu CC. Environmental lead exposure and urate excretion in the general population. Am J Med 2002; 113: 563-568.
15. Lin JL, Lin-Tan DT, Hsu KH, Yu CC. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 2003; 348: 277-286.
16. Ford ES. Vitamin supplement use and diabetes mellitus incidence among adults in the United States. Am J Epidemiol 2001; 153: 892-897.
17. Jones CA, Krolewski AS, Rogus J et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 2005; 67: 1684-1691.
18. Tsaih SW, Korrick S, Schwartz J et al. Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect 2004; 112: 1178-1182.
19. Liou SH, Wu TN, Chiang HC et al. Three-year survey of blood lead levels in 8828 Taiwanese adults. Int Arch Occup Environ Health 1996; 68: 80-87.
20. Batuman V. Lead nephropathy, gout, and hypertension. Am J Med Sci 1993; 305: 241-247.
21. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 1997; 105: 928-939.
22. Marsden PA. Increased body lead burden - cause or consequence of chronic renal insufficiency? N Engl J Med 2003; 348: 345-347.
23. Van de Vyver FL, D'Haese PC, Visser WJ et al. Bone lead in dialysis patients. Kidney Int 1988; 33: 601-607.
24. Batuman V, Maesaka JK, Haddad B et al. The role of lead in gout nephropathy. N Engl J Med 1981; 304: 520-523.
25. Batuman V, Landy E, Maesaka JK, Wedeen RP. Contribution of lead to hypertension with renal impairment. N Engl J Med 1983; 309: 17-21.
26. Emmerson BT. Lead stores in patients with renal insufficiency. Nephron 1991; 58: 233-234.
27. Khalil-Manesh F, Gonick HC, Cohen A et al. A Experimental model of lead nephropathy. II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA). Environ Res 1992; 58: 35-54.
28. Ding Y, Vaziri ND, Gonick HC. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res 1998; 76: 107-113.
29. Boscolo P, Carmignani M. Neurohumoral blood pressure regulation in lead exposure. Environ Health Perspect 1988; 78: 101-106.
30. Behringer D, Craswell P, Mohl C et al. Urinary lead excretion in uremic patients. Nephron 1986; 42: 323-329.
31. Isaksson B. Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 1980; 33: 4-5.
32. Lin JL, Yu CC, Lin-Tan DT, Ho HH. Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout. Kidney Int 2001; 60: 266-271.
33. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470.